share_log

康方生物：董事會會議召開日期

AKESO: DATE OF BOARD MEETING

Hong Kong Stock Exchange ·  Aug 16 06:00
Summary by Moomoo AI
康方生物科技（開曼）有限公司（「本公司」）將於2024年8月28日（星期三）召開董事會會議，主要目的是考慮及批准截至2024年6月30日止六個月的中期業績報告及其發布。會議將由主席兼執行董事夏瑜博士主持，並有其他執行董事李百勇博士、王忠民博士、張鵬博士，非執行董事謝榕剛先生，以及獨立非執行董事曾駿文博士、徐岩博士及TAN Bo先生參與。該會議的通知於2024年8月16日由康方生物發出。
康方生物科技（開曼）有限公司（「本公司」）將於2024年8月28日（星期三）召開董事會會議，主要目的是考慮及批准截至2024年6月30日止六個月的中期業績報告及其發布。會議將由主席兼執行董事夏瑜博士主持，並有其他執行董事李百勇博士、王忠民博士、張鵬博士，非執行董事謝榕剛先生，以及獨立非執行董事曾駿文博士、徐岩博士及TAN Bo先生參與。該會議的通知於2024年8月16日由康方生物發出。
Akeso Biopharma (Cayman) Limited ("the Company") will hold a board of directors meeting on Wednesday, August 28, 2024 to consider and approve the interim performance report for the six months ended June 30, 2024 and its release. The meeting will be chaired by Chairman and Executive Director Dr. Xia Yu, with other Executive Directors Dr. Li Baiyong, Dr. Wang Zhongmin, and Dr. Zhang Peng, Non-Executive Director Mr. Xie Ronggang, and Independent Non-Executive Directors Dr. Zeng Junwen, Dr. Xu Yan, and Mr. TAN Bo attending. The notice of the meeting was issued by Akeso Biopharma on August 16, 2024.
Akeso Biopharma (Cayman) Limited ("the Company") will hold a board of directors meeting on Wednesday, August 28, 2024 to consider and approve the interim performance report for the six months ended June 30, 2024 and its release. The meeting will be chaired by Chairman and Executive Director Dr. Xia Yu, with other Executive Directors Dr. Li Baiyong, Dr. Wang Zhongmin, and Dr. Zhang Peng, Non-Executive Director Mr. Xie Ronggang, and Independent Non-Executive Directors Dr. Zeng Junwen, Dr. Xu Yan, and Mr. TAN Bo attending. The notice of the meeting was issued by Akeso Biopharma on August 16, 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more